Title: Europe POCT Device Market to Grow at a CAGR of over 8.6% Through 2024
1Europe POCT Device Market
Europe POCT Device Market to Grow at a CAGR of
over 8.6 Through 2024
Europe POCT Device Market is expected to reach
USD 11.68bin 2016, at a CAGR of 8.6 in the
forecast period 2017 to 2024. The new market
report contains data for historic years 2015, the
base year of calculation is 2016 and the forecast
period is 2017 to 2024. Blood Glucose testing
kits market has the largest market segment in
Euope POCT device market.
Browse Full Report and Details
TOC https//databridgemarketresearch.com/reports/
europe-poct-device-market/
2Report Description
The Europe POCT Device Market is highly
concentrated to a few big players and rest to
local players who cater to domestic markets only.
Roche dominated the Euope POCT device market
market accounting for the highest market share in
2016, followed by Siemens and Abbott. Other
players in this market include Alere Inc.,
Becton, Dickinson and Company, Johnson Johnson
Services Inc., PTS Diagnostics, Instrumentation
Laboratory, Nova Biomedical, Beckman Coulter,
Inc. among others holds 41.1 of the Europe POCT
device market in 2016.
Request For Free Sample Report
https//databridgemarketresearch.com/request-a-sa
mple/?dbmreurope-poct-device-market
3Key Drivers
- Rising cost of POCT devices is the factor which
may hinder the growth of this market. - Many companies are making continuous efforts and
advancesto make products more up to date, along
with propelled innovations with reduced sample
volume or less blood on portable devices. So as
to create development for in-vitro diagnostics
organizations in the market. - Emerging POCT device market as well as emergence
of Microfluidic lab-on-a-chip technologieswill
drive the market in future.
Speak to Expert https//databridgemarketresearch
.com/inquire-before-buying/?dbmreurope-poct-devic
e-market
4Recent Developments
- In May, 2017, Abbott announced CE Mark approval
and its use of the new Rx Insertable Cardiac
Monitor (ICM), which is the worlds first
smartphone compatible ICM to identify or detect
cardiac arrhythmias, including atrial
fibrillation (AF), for therapy. - In May, 2017, Abbott announced the national
reimbursement for freestyle Libre in France,
providing access to revolutionary technology for
people suffering with diabetes. This would help
thousands of people to have access to test type 1
and type 2 diabetes.
Request for Customization _at_ sopan.gedam_at_databridg
emarketresearch.com
5About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam1-888-387-2818 (Toll
Free) sopan.gedam_at_databridgemarketresearch.com